PSMA PET/MR - Gallium-68 labeled PSMA-HBED-CC
19-10020928
Phase 2 small_molecule active
Quick answer
PSMA PET/MR - Gallium-68 labeled PSMA-HBED-CC for Prostate Cancer is a Phase 2 program (small_molecule) at Telix Pharmaceuticals Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Telix Pharmaceuticals Ltd
- Indication
- Prostate Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active